BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 27821590)

  • 1. Heparan Sulfate and Heparin Promote Faithful Prion Replication in Vitro by Binding to Normal and Abnormal Prion Proteins in Protein Misfolding Cyclic Amplification.
    Imamura M; Tabeta N; Kato N; Matsuura Y; Iwamaru Y; Yokoyama T; Murayama Y
    J Biol Chem; 2016 Dec; 291(51):26478-26486. PubMed ID: 27821590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Elucidation of the Molecular Basis of Abnormal Prion Protein (PrP) Formation in a Cell-Free System Using Baculovirus and Insect Cell-derived Recombinant PrP].
    Imamura M; Mori T; Takatsuki H; Iwamaru Y; Atarashi R
    Yakugaku Zasshi; 2019; 139(7):989-992. PubMed ID: 31257257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro amplification of scrapie and chronic wasting disease PrP(res) using baculovirus-expressed recombinant PrP as substrate.
    Faburay B; Tark D; Kanthasamy AG; Richt JA
    Prion; 2014; 8(6):393-403. PubMed ID: 25495764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preserving prion strain identity upon replication of prions in vitro using recombinant prion protein.
    Makarava N; Savtchenko R; Lasch P; Beekes M; Baskakov IV
    Acta Neuropathol Commun; 2018 Sep; 6(1):92. PubMed ID: 30208966
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Eraña H; Fernández-Borges N; Elezgarai SR; Harrathi C; Charco JM; Chianini F; Dagleish MP; Ortega G; Millet Ó; Castilla J
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosylphosphatidylinositol anchor-dependent stimulation pathway required for generation of baculovirus-derived recombinant scrapie prion protein.
    Imamura M; Kato N; Yoshioka M; Okada H; Iwamaru Y; Shimizu Y; Mohri S; Yokoyama T; Murayama Y
    J Virol; 2011 Mar; 85(6):2582-8. PubMed ID: 21228241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of prion protein glycosylation in replication of human prions by protein misfolding cyclic amplification.
    Camacho MV; Telling G; Kong Q; Gambetti P; Notari S
    Lab Invest; 2019 Nov; 99(11):1741-1748. PubMed ID: 31249376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthetic Prion Selection and Adaptation.
    Bistaffa E; Moda F; Virgilio T; Campagnani I; De Luca CMG; Rossi M; Salzano G; Giaccone G; Tagliavini F; Legname G
    Mol Neurobiol; 2019 Apr; 56(4):2978-2989. PubMed ID: 30074230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly efficient protein misfolding cyclic amplification.
    Gonzalez-Montalban N; Makarava N; Ostapchenko VG; Savtchenk R; Alexeeva I; Rohwer RG; Baskakov IV
    PLoS Pathog; 2011 Feb; 7(2):e1001277. PubMed ID: 21347353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultra-efficient PrP(Sc) amplification highlights potentialities and pitfalls of PMCA technology.
    Cosseddu GM; Nonno R; Vaccari G; Bucalossi C; Fernandez-Borges N; Di Bari MA; Castilla J; Agrimi U
    PLoS Pathog; 2011 Nov; 7(11):e1002370. PubMed ID: 22114554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosaminoglycan sulfation determines the biochemical properties of prion protein aggregates.
    Ellett LJ; Coleman BM; Shambrook MC; Johanssen VA; Collins SJ; Masters CL; Hill AF; Lawson VA
    Glycobiology; 2015 Jul; 25(7):745-55. PubMed ID: 25701659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insect cell-derived cofactors become fully functional after proteinase K and heat treatment for high-fidelity amplification of glycosylphosphatidylinositol-anchored recombinant scrapie and BSE prion proteins.
    Imamura M; Kato N; Okada H; Yoshioka M; Iwamaru Y; Shimizu Y; Mohri S; Yokoyama T; Murayama Y
    PLoS One; 2013; 8(12):e82538. PubMed ID: 24367521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prion formation, but not clearance, is supported by protein misfolding cyclic amplification.
    Shikiya RA; Eckland TE; Young AJ; Bartz JC
    Prion; 2014; 8(6):415-20. PubMed ID: 25482601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a methodology for large-scale production of prions for biological and structural studies.
    Concha-Marambio L; Wang F; Armijo E; Gorski D; Ramirez F; Scowcroft A; Pritzkow S; Soto C
    Front Mol Biosci; 2023; 10():1184029. PubMed ID: 37635939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient in vitro amplification of a mouse-adapted scrapie prion protein.
    Murayama Y; Yoshioka M; Yokoyama T; Iwamaru Y; Imamura M; Masujin K; Yoshiba S; Mohri S
    Neurosci Lett; 2007 Feb; 413(3):270-3. PubMed ID: 17174030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclic amplification of prion protein misfolding.
    Barria MA; Gonzalez-Romero D; Soto C
    Methods Mol Biol; 2012; 849():199-212. PubMed ID: 22528092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein Misfolding Cyclic Amplification Cross-Species Products of Mouse-Adapted Scrapie Strain 139A and Hamster-Adapted Scrapie Strain 263K with Brain and Muscle Tissues of Opposite Animals Generate Infectious Prions.
    Gao C; Han J; Zhang J; Wei J; Zhang BY; Tian C; Zhang J; Shi Q; Dong XP
    Mol Neurobiol; 2017 Jul; 54(5):3771-3782. PubMed ID: 27259989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strain-specific role of RNAs in prion replication.
    Saá P; Sferrazza GF; Ottenberg G; Oelschlegel AM; Dorsey K; Lasmézas CI
    J Virol; 2012 Oct; 86(19):10494-504. PubMed ID: 22811520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. De novo generation of infectious prions in vitro produces a new disease phenotype.
    Barria MA; Mukherjee A; Gonzalez-Romero D; Morales R; Soto C
    PLoS Pathog; 2009 May; 5(5):e1000421. PubMed ID: 19436715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding Intra-Species and Inter-Species Prion Conversion and Zoonotic Potential Using Protein Misfolding Cyclic Amplification.
    Peden AH; Suleiman S; Barria MA
    Front Aging Neurosci; 2021; 13():716452. PubMed ID: 34413769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.